Icecure Medical Ltd Quick Ratio (ICCM) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Icecure Medical Ltd  (NASDAQ: ICCM)

Icecure Medical Ltd's Quick Ratio

ICCM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Icecure Medical Ltd's Cash & cash equivalent, this led to improvement in Icecure Medical Ltd's Quick Ratio to 3.9, Quick Ratio remained below Icecure Medical Ltd average.

Within Medical Equipment & Supplies industry 59 other companies have achieved higher Quick Ratio than Icecure Medical Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from to 881.

Explain Quick Ratio?
How much Cash & cash equivalents ICCM´s has?
What are ICCM´s Current Liabilities?




ICCM Quick Ratio (Dec 31 2025)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2024)
Q4
Y / Y Current Liabilities Change -47.26 % 564.75 % 5.11 % 26.64 % 13.82 %
Y / Y Cash & cash equivalent Change 17.62 % -7.82 % -51.34 % -19.57 % -56.04 %
Quick Ratio MRQ 3.9 1.93 0.73 1.93 1.75
ICCM's Total Ranking # 881 # # # #
Seq. Current Liabilities Change -50.65 % -37.04 % 58.83 % 6.87 % 522.01 %
Seq. Cash & cash equivalent Change 0 % 65.28 % -39.5 % 17.62 % -21.63 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 379
Overall Market # 881


Quick Ratio Statistics
High Average Low
6.75 4.36 1.93
(Dec 31 2021)   (Dec 31 2025)




Financial Statements
Icecure Medical Ltd's Current Liabilities $ 2 Millions Visit ICCM's Balance sheet
Icecure Medical Ltd's Cash & cash equivalent $ 9 Millions Visit ICCM's Balance sheet
Source of ICCM's Sales Visit ICCM's Sales by Geography


Cumulative Icecure Medical Ltd's Quick Ratio

ICCM's Quick Ratio for the trailling 12 Months

ICCM Quick Ratio

(Dec 31 2025)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 20.52 % 38.22 % -6.08 % -11.21 % -18.67 %
Y / Y Cash & cash equivalent TTM Growth -18.47 % -37.24 % -37.5 % -41.53 % -48.56 %
Quick Ratio TTM 1.7 1.47 1.86 2.24 2.51
Total Ranking TTM # 2408 # # # #
Seq. Current Liabilities TTM Growth -9.77 % 23.12 % 2.15 % 6.21 % 3.47 %
Seq. Cash & cash equivalent TTM Growth 4.34 % -2.4 % -15.28 % -5.5 % -19.69 %


On the trailing twelve months basis ICCM Cash & cash equivalent increased by 17.62 % in Q4 2025 year on year, while Current Liabilities dropped to $2 millions, this led to increase in in Icecure Medical Ltd's Quick Ratio to 1.7, Quick Ratio remained below ICCM average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 125 other companies have achieved higher Quick Ratio than Icecure Medical Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 2408.

Explain Quick Ratio?
How much Cash & cash equivalents ICCM´s has?
What are ICCM´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 126
Healthcare Sector # 590
Within the Market # 2408


trailing twelve months Quick Ratio Statistics
High Average Low
6.37 5.16 2.86
(Dec 31 2021)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Pulse Biosciences Inc   10.19 $ 80.735  Millions$ 7.923  Millions
Alpha Tau Medical Ltd  10.05 $ 76.903  Millions$ 7.652  Millions
Rxsight Inc   9.92 $ 228.128  Millions$ 22.991  Millions
Lemaitre Vascular Inc   9.89 $ 359.120  Millions$ 36.323  Millions
Profound Medical Corp   9.83 $ 59.723  Millions$ 6.075  Millions
Logicmark Inc  9.08 $ 15.368  Millions$ 1.692  Millions
Ceribell Inc   8.86 $ 159.261  Millions$ 17.984  Millions
Bluejay Diagnostics Inc  8.65 $ 5.165  Millions$ 0.597  Millions
Delcath Systems Inc   8.39 $ 91.036  Millions$ 10.849  Millions
Sight Sciences Inc   8.34 $ 91.965  Millions$ 11.027  Millions
Carlsmed Inc   7.69 $ 109.793  Millions$ 14.280  Millions
EBR Systems, Inc.  7.57 $ 101.595  Millions$ 13.422  Millions
Inmode Ltd   7.16 $ 555.244  Millions$ 77.569  Millions
Beta Bionics Inc   7.09 $ 219.125  Millions$ 30.924  Millions
Orchestra Biomed Holdings Inc   6.66 $ 106.512  Millions$ 15.985  Millions
Innovative Eyewear Inc   6.23 $ 6.511  Millions$ 1.045  Millions
Nutriband Inc   5.83 $ 4.575  Millions$ 0.784  Millions
Cvrx inc   5.69 $ 75.708  Millions$ 13.317  Millions
Transmedics Group Inc   5.47 $ 488.366  Millions$ 89.305  Millions
Autonomix Medical Inc   5.35 $ 9.136  Millions$ 1.707  Millions
Inspiremd Inc   5.06 $ 54.211  Millions$ 10.712  Millions
Perspective Therapeutics Inc   5.05 $ 144.737  Millions$ 28.679  Millions
Iradimed Corporation  5.03 $ 51.159  Millions$ 10.180  Millions
Collplant Biotechnologies Ltd  5.00 $ 5.950  Millions$ 1.191  Millions
Soleno Therapeutics Inc  4.98 $ 305.472  Millions$ 61.363  Millions
Heartflow Inc   4.85 $ 176.786  Millions$ 36.448  Millions
Sensus Healthcare Inc   4.68 $ 22.083  Millions$ 4.722  Millions
Orasure Technologies Inc  4.64 $ 199.278  Millions$ 42.947  Millions
Outset Medical Inc   4.49 $ 168.946  Millions$ 37.630  Millions
Irhythm Holdings Inc   4.46 $ 583.763  Millions$ 131.003  Millions

Date modified: 2026-07-07T11:26:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.